Finally, ψ-bufarenogin is a high-/intermediate polarity compound that showed satisfactory therapeutic effect against liver cancer xenografts by suppressing the MAPK and PI3K/Akt pathways [54]. The gene discussed is PIK3CD; the disease is liver cancer.